LRE earnings

Net income attributable to common shareholders increased by 35.1% to JPY846.8 million, or $5.9 million TOKYO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (NASDAQ:LRE) ("LRE" or the "Company"), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, and which develops and operates the ENT TERRACE brand of extended-stay hotels, today announced financial results for the fiscal year ended June 30, 2025. Total revenue was JPY18.8 billion ($130.7 million) for the fiscal year ended June 30, 2025, compared to JPY19.0 billion for the fiscal year ended June 30, 2024, a decrease

TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Lead Real Estate Co., Ltd (NASDAQ:LRE) ("LRE" or the "Company"), a Japanese real estate developer of luxury residential properties —including single-family homes and condominiums across Tokyo, Kanagawa Prefecture, and Sapporo—and operator of the ENT TERRACE brand of extended-stay hotels, today announced that it will release its financial results for the fiscal year ended June 30, 2025, before U.S. market open on Monday, November 3, 2025. Following the release, the Company will host a conference call and webcast to discuss its results and outlook. Conference Call Details Date: Monday, November 3, 2025 Time: 8:30 AM Eastern Time (10:30 PM Japan Sta

TOKYO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Lead Real Estate Co., LTD. (NASDAQ:LRE), ("LRE" or the "Company"), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, and which develops and operates the ENT TERRACE brand of extended-stay hotels, today announced it will host a conference call on Friday, November 22, 2024, at 8:30 AM Eastern time to discuss the company's fiscal year 2024 financial results ended June 30, 2024. These results will be announced Thursday, November 21, shortly after 4:00 PM Eastern time. To participate in the conference call, please dial 1-877-407-0752 or 1-201-3